Cargando…
Radiomics Feature Activation Maps as a New Tool for Signature Interpretability
INTRODUCTION: In the field of personalized medicine, radiomics has shown its potential to support treatment decisions. However, the limited feature interpretability hampers its introduction into the clinics. Here, we propose a new methodology to create radiomics feature activation maps, which allows...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753181/ https://www.ncbi.nlm.nih.gov/pubmed/33364192 http://dx.doi.org/10.3389/fonc.2020.578895 |
_version_ | 1783626017590476800 |
---|---|
author | Vuong, Diem Tanadini-Lang, Stephanie Wu, Ze Marks, Robert Unkelbach, Jan Hillinger, Sven Eboulet, Eric Innocents Thierstein, Sandra Peters, Solange Pless, Miklos Guckenberger, Matthias Bogowicz, Marta |
author_facet | Vuong, Diem Tanadini-Lang, Stephanie Wu, Ze Marks, Robert Unkelbach, Jan Hillinger, Sven Eboulet, Eric Innocents Thierstein, Sandra Peters, Solange Pless, Miklos Guckenberger, Matthias Bogowicz, Marta |
author_sort | Vuong, Diem |
collection | PubMed |
description | INTRODUCTION: In the field of personalized medicine, radiomics has shown its potential to support treatment decisions. However, the limited feature interpretability hampers its introduction into the clinics. Here, we propose a new methodology to create radiomics feature activation maps, which allows to identify the spatial-anatomical locations responsible for signature activation based on local radiomics. The feasibility of this technique will be studied for histological subtype differentiation (adenocarcinoma versus squamous cell carcinoma) in non-small cell lung cancer (NSCLC) using computed tomography (CT) radiomics. MATERIALS AND METHODS: Pre-treatment CT scans were collected from a multi-centric Swiss trial (training, n=73, IIIA/N2 NSCLC, SAKK 16/00) and an independent cohort (validation, n=32, IIIA/N2/IIIB NSCLC). Based on the gross tumor volume (GTV), four peritumoral region of interests (ROI) were defined: lung_exterior (expansion into the lung), iso_exterior (expansion into lung and soft tissue), gradient (GTV border region), GTV+Rim (GTV and iso_exterior). For each ROI, 154 radiomic features were extracted using an in-house developed software implementation (Z-Rad, Python v2.7.14). Features robust against delineation variability served as an input for a multivariate logistic regression analysis. Model performance was quantified using the area under the receiver operating characteristic curve (AUC) and verified using five-fold cross validation and internal validation. Local radiomic features were extracted from the GTV+Rim ROI using non-overlapping 3x3x3 voxel patches previously marked as GTV or rim. A binary activation map was created for each patient using the median global feature value from the training. The ratios of activated/non-activated patches of GTV and rim regions were compared between histological subtypes (Wilcoxon test). RESULTS: Iso_exterior, gradient, GTV+Rim showed good performances for histological subtype prediction (AUC(training)=0.68–0.72 and AUC(validation)=0.73–0.74) whereas GTV and lung_exterior models failed validation. GTV+Rim model feature activation maps showed that local texture feature distribution differed significantly between histological subtypes in the rim (p=0.0481) but not in the GTV (p=0.461). CONCLUSION: In this exploratory study, radiomics-based prediction of NSCLC histological subtypes was predominantly based on the peritumoral region indicating that radiomics activation maps can be useful for tracing back the spatial location of regions responsible for signature activation. |
format | Online Article Text |
id | pubmed-7753181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77531812020-12-23 Radiomics Feature Activation Maps as a New Tool for Signature Interpretability Vuong, Diem Tanadini-Lang, Stephanie Wu, Ze Marks, Robert Unkelbach, Jan Hillinger, Sven Eboulet, Eric Innocents Thierstein, Sandra Peters, Solange Pless, Miklos Guckenberger, Matthias Bogowicz, Marta Front Oncol Oncology INTRODUCTION: In the field of personalized medicine, radiomics has shown its potential to support treatment decisions. However, the limited feature interpretability hampers its introduction into the clinics. Here, we propose a new methodology to create radiomics feature activation maps, which allows to identify the spatial-anatomical locations responsible for signature activation based on local radiomics. The feasibility of this technique will be studied for histological subtype differentiation (adenocarcinoma versus squamous cell carcinoma) in non-small cell lung cancer (NSCLC) using computed tomography (CT) radiomics. MATERIALS AND METHODS: Pre-treatment CT scans were collected from a multi-centric Swiss trial (training, n=73, IIIA/N2 NSCLC, SAKK 16/00) and an independent cohort (validation, n=32, IIIA/N2/IIIB NSCLC). Based on the gross tumor volume (GTV), four peritumoral region of interests (ROI) were defined: lung_exterior (expansion into the lung), iso_exterior (expansion into lung and soft tissue), gradient (GTV border region), GTV+Rim (GTV and iso_exterior). For each ROI, 154 radiomic features were extracted using an in-house developed software implementation (Z-Rad, Python v2.7.14). Features robust against delineation variability served as an input for a multivariate logistic regression analysis. Model performance was quantified using the area under the receiver operating characteristic curve (AUC) and verified using five-fold cross validation and internal validation. Local radiomic features were extracted from the GTV+Rim ROI using non-overlapping 3x3x3 voxel patches previously marked as GTV or rim. A binary activation map was created for each patient using the median global feature value from the training. The ratios of activated/non-activated patches of GTV and rim regions were compared between histological subtypes (Wilcoxon test). RESULTS: Iso_exterior, gradient, GTV+Rim showed good performances for histological subtype prediction (AUC(training)=0.68–0.72 and AUC(validation)=0.73–0.74) whereas GTV and lung_exterior models failed validation. GTV+Rim model feature activation maps showed that local texture feature distribution differed significantly between histological subtypes in the rim (p=0.0481) but not in the GTV (p=0.461). CONCLUSION: In this exploratory study, radiomics-based prediction of NSCLC histological subtypes was predominantly based on the peritumoral region indicating that radiomics activation maps can be useful for tracing back the spatial location of regions responsible for signature activation. Frontiers Media S.A. 2020-12-08 /pmc/articles/PMC7753181/ /pubmed/33364192 http://dx.doi.org/10.3389/fonc.2020.578895 Text en Copyright © 2020 Vuong, Tanadini-Lang, Wu, Marks, Unkelbach, Hillinger, Eboulet, Thierstein, Peters, Pless, Guckenberger and Bogowicz http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Vuong, Diem Tanadini-Lang, Stephanie Wu, Ze Marks, Robert Unkelbach, Jan Hillinger, Sven Eboulet, Eric Innocents Thierstein, Sandra Peters, Solange Pless, Miklos Guckenberger, Matthias Bogowicz, Marta Radiomics Feature Activation Maps as a New Tool for Signature Interpretability |
title | Radiomics Feature Activation Maps as a New Tool for Signature Interpretability |
title_full | Radiomics Feature Activation Maps as a New Tool for Signature Interpretability |
title_fullStr | Radiomics Feature Activation Maps as a New Tool for Signature Interpretability |
title_full_unstemmed | Radiomics Feature Activation Maps as a New Tool for Signature Interpretability |
title_short | Radiomics Feature Activation Maps as a New Tool for Signature Interpretability |
title_sort | radiomics feature activation maps as a new tool for signature interpretability |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753181/ https://www.ncbi.nlm.nih.gov/pubmed/33364192 http://dx.doi.org/10.3389/fonc.2020.578895 |
work_keys_str_mv | AT vuongdiem radiomicsfeatureactivationmapsasanewtoolforsignatureinterpretability AT tanadinilangstephanie radiomicsfeatureactivationmapsasanewtoolforsignatureinterpretability AT wuze radiomicsfeatureactivationmapsasanewtoolforsignatureinterpretability AT marksrobert radiomicsfeatureactivationmapsasanewtoolforsignatureinterpretability AT unkelbachjan radiomicsfeatureactivationmapsasanewtoolforsignatureinterpretability AT hillingersven radiomicsfeatureactivationmapsasanewtoolforsignatureinterpretability AT ebouletericinnocents radiomicsfeatureactivationmapsasanewtoolforsignatureinterpretability AT thiersteinsandra radiomicsfeatureactivationmapsasanewtoolforsignatureinterpretability AT peterssolange radiomicsfeatureactivationmapsasanewtoolforsignatureinterpretability AT plessmiklos radiomicsfeatureactivationmapsasanewtoolforsignatureinterpretability AT guckenbergermatthias radiomicsfeatureactivationmapsasanewtoolforsignatureinterpretability AT bogowiczmarta radiomicsfeatureactivationmapsasanewtoolforsignatureinterpretability |